Evidence-based recommendations for the practical management of Familial Mediterranean Fever.
about
Colchicine for prevention of cardiovascular eventsThe Relationship between NALP3 and Autoinflammatory SyndromesFamilial Mediterranean fever: current perspectivesEULAR recommendations for the management of familial Mediterranean feverP wave dispersion and QT dispersion in adult Turkish migrants with familial mediterranean fever living in Germany.Relationship between clinical findings and genetic mutations in patients with familial Mediterranean fever.A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever.Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for ManagementEvidence-based recommendations for genetic diagnosis of familial Mediterranean fever.Familial Mediterranean fever in children and adolescents: factors for colchicine dosage and predicting parameters for dose increase.The adverse outcome pathway (AOP) for chemical binding to tubulin in oocytes leading to aneuploid offspring.What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review.Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis.Biologic therapy in familial Mediterranean fever.A Comprehensive Overview of the Hereditary Periodic Fever Syndromes.Canakinumab for the treatment of familial Mediterranean fever.International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome.The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases.Autoinflammatory Diseases with Periodic Fevers.The experience of canakinumab in renal amyloidosis secondary to Familial Mediterranean fever.Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?Clinical update on inflammasomopathies.Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants.Familial Mediterranean fever patients homozygous for E148Q variant.Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.Familial mediterranean fever-anticipated rise in Western Europe.Association between colchicine resistance and vitamin D in familial Mediterranean fever.Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.Rapid resolution of protracted febrile myalgia syndrome with anakinra: Report of two cases.[Self-medication to treat pain in attacks of familial Mediterranean fever: aiming to find a new approach to pain management].
P2860
Q24186361-38183B0D-00C1-4C0A-B964-C5581E55BCD0Q26749025-84235556-A40C-46CB-A172-3EF3C63893CCQ26751292-358A9988-6B5C-45F2-B188-66B555958B4FQ26775286-029A632C-9288-40B1-9873-FB09C3E1154DQ34102054-0E214883-D4B7-4700-92C2-570D4BFE2AA1Q36457693-32211323-C4AF-46DE-950B-3D71B165BD24Q37708258-FAD82F1E-15DC-4160-AD23-C4151A3EA76EQ37716794-B9620D98-793E-4F6C-BCBC-B9956C9B2609Q38335115-4EE7BEFA-A49F-4AA9-B5D3-4979D757C0D8Q38599628-5B816B85-9621-4B38-BE3E-E19DEC87BBE7Q38637834-5D90FE62-A27D-4F38-9C56-94A214ED2529Q38681895-DF512F4A-73AE-4A94-A64A-595F58F6DBF5Q38718132-B6A10ADC-5103-49EE-8354-A3E764FF1F67Q38759360-60DD7FE5-C760-42CF-89D7-47AB21B9F0E4Q38805718-E36B444C-F74B-4E9A-8E86-9F9612963C59Q38865019-12B76B86-55E5-492B-8CFD-057CF4B0E625Q38977041-545F585A-B505-4987-BCFA-DF934CB4BF9FQ39132605-7FE4E50C-035C-4DD8-A9FD-FC17A4CD2DD8Q39384980-8A493C19-531F-4A6D-B1E7-F70DB9022B77Q39426709-FBFFE2E5-B682-4042-AB75-4BED41C7E080Q40040556-6FAA74A2-E846-4B53-BDC8-C182D79BDAB2Q40062051-41473684-490F-402D-A372-20ACC5CF716AQ40079604-08FC0411-6F00-4A0E-955B-FE9173C6A54CQ40087177-343B3B12-0893-4B71-82F5-859DA529B092Q40095229-5DD15EB8-782E-4E89-AA25-2386F709AE9DQ40100395-45E876FA-45F1-4377-9617-44E0278C91C5Q40109702-FAD10B88-E9E6-4CC3-98E8-3B89E570B45AQ40151942-B17B6A50-B5F9-47F8-AC6D-98BACADA1F10Q40154874-F3ADBB5C-7E5C-416D-A87D-AEF405086FE5Q40217693-5585EBCE-C531-4756-BEC3-E962A90218F0Q40224961-91F8C0A6-9C41-4F89-9074-15C962227052
P2860
Evidence-based recommendations for the practical management of Familial Mediterranean Fever.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Evidence-based recommendations ...... Familial Mediterranean Fever.
@en
type
label
Evidence-based recommendations ...... Familial Mediterranean Fever.
@en
prefLabel
Evidence-based recommendations ...... Familial Mediterranean Fever.
@en
P2093
P1476
Evidence-based recommendations ...... Familial Mediterranean Fever.
@en
P2093
Avi Livneh
Eldad Ben-Chetrit
Gilles Grateau
Isabelle Kone-Paut
Isabelle Touitou
Michael Rozenbaum
Ruth Gershoni-Baruch
Serge Amselem
Shai Padeh
Véronique Hentgen
P304
P356
10.1016/J.SEMARTHRIT.2013.04.011
P577
2013-06-03T00:00:00Z